European Journal of Dermatology
MENUDermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera Volume 12, numéro 6, November - December 2002
Illustrations
Bayindir Medical Centre, Department of Dematology, Mesa Park Sitesi, Sedir Apt. Daire: 44, Oran 06450 Ankara/Turkey.
- Page(s) : 586-8
- Année de parution : 2002
Hydroxyurea (HU) is a hydroxylated derivative of urea commonly used to treat a variety of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, or essential thrombocythemia as well as refractory psoriasis. HU is usually well tolerated, but long-term HU therapy can produce several cutaneous abnormalities [1-5]. Although the occurrence of dermatomyositis-like changes during long-term HU therapy are well known, [...]